Page last updated: 2024-10-24

transition between fast and slow fiber

Definition

Target type: biologicalprocess

The process of conversion of fast-contracting muscle fibers to a slower character. This may involve slowing of contractile rate, slow myosin gene induction, increase in oxidative metabolic properties, altered electrophysiology and altered innervation. This process also regulates skeletal muscle adapatation. [GOC:ef, GOC:mtg_muscle]

The transition between fast and slow muscle fibers is a complex process influenced by a variety of factors, including genetics, age, and training. It involves changes in gene expression, protein synthesis, and cellular structure. Here's a detailed breakdown:

**1. Gene Expression:**
- The expression of genes responsible for producing fast and slow muscle proteins is altered.
- Fast fibers express genes like Myosin Heavy Chain (MHC) IIa, IIx, and IIb, while slow fibers express MHC I.
- During transition, the expression of fast MHC isoforms decreases, and the expression of slow MHC isoforms increases.

**2. Protein Synthesis:**
- The production of proteins involved in muscle contraction and metabolism is adjusted.
- Fast fibers synthesize proteins associated with rapid contraction, while slow fibers synthesize proteins for endurance.
- This shift in protein synthesis reflects the changing metabolic needs of the fiber type.

**3. Cellular Structure:**
- The physical structure of the fiber changes.
- Fast fibers have a larger diameter, higher glycogen content, and a greater number of mitochondria compared to slow fibers.
- During transition, these structural differences gradually shift towards the characteristics of slow fibers.

**4. Metabolic Enzymes:**
- Enzymes involved in energy production and utilization are modified.
- Fast fibers rely primarily on glycolysis for energy, while slow fibers utilize oxidative phosphorylation.
- This metabolic shift is facilitated by changes in enzyme activity and expression.

**5. Fiber Type Distribution:**
- The proportion of fast and slow fibers within a muscle can change over time.
- Training can lead to an increase in the percentage of slow fibers in a muscle, while detraining can result in an increase in fast fibers.

**6. Factors Influencing Transition:**
- Genetics plays a significant role in determining the inherent fiber type distribution.
- Age can impact muscle fiber type composition, with a gradual shift towards slow fibers as we age.
- Training, especially endurance training, promotes the transition from fast to slow fibers.

**7. Mechanisms of Transition:**
- While the exact mechanisms are still being investigated, it is believed that signaling pathways involving growth factors, hormones, and transcription factors play a crucial role in regulating the transition.

**8. Reversibility:**
- The transition between fast and slow fibers is to some extent reversible.
- If training or other factors promoting slow fiber development cease, the muscle can revert back to a more fast-fiber dominant state.

**9. Significance:**
- The ability of muscle fibers to adapt to different demands through transitioning between fast and slow fiber types is essential for maintaining muscle function and performance across different activities and physiological conditions.

**10. Implications for Health:**
- Understanding this process is crucial for developing effective exercise interventions and treatments for various conditions, including muscle diseases, age-related decline, and metabolic disorders.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoformA protein phosphatase 3 catalytic subunit alpha that is encoded in the genome of human. [PRO:CNA, UniProtKB:Q08209]Homo sapiens (human)
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2A sarcoplasmic/endoplasmic reticulum calcium ATPase 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P16615]Homo sapiens (human)

Compounds (8)

CompoundDefinitionClassesRoles
2,5-di-tert-butylhydroquinone2,5-di-tert-butylbenzene-1,4-diol : A member of the class of hydroquinones that is benzene-1,4-diol substituted by tert-butyl groups at position 2 and 5.hydroquinones
paxillinepaxilline : An indole diterpene alkaloid with formula C27H33NO4 isolated from Penicillium paxilli. It is a potent inhibitor of large conductance Ca2(+)- and voltage-activated K(+) (BK)-type channels.

paxilline: structure given in first source; RN given refers to (2R-(2alpha,4bbeta,6aalpha,12bbeta,12calpha,14abeta))-isomer
diterpene alkaloid;
enone;
organic heterohexacyclic compound;
terpenoid indole alkaloid;
tertiary alcohol
anticonvulsant;
Aspergillus metabolite;
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor;
genotoxin;
geroprotector;
mycotoxin;
Penicillium metabolite;
potassium channel blocker
tacrolimustacrolimus (anhydrous) : A macrolide lactam containing a 23-membered lactone ring, originally isolated from the fermentation broth of a Japanese soil sample that contained the bacteria Streptomyces tsukubaensis.

Tacrolimus: A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro.
macrolide lactambacterial metabolite;
immunosuppressive agent
curcumincurcumin : A beta-diketone that is methane in which two of the hydrogens are substituted by feruloyl groups. A natural dyestuff found in the root of Curcuma longa.

Curcumin: A yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. Curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes.
aromatic ether;
beta-diketone;
diarylheptanoid;
enone;
polyphenol
anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
biological pigment;
contraceptive drug;
dye;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
EC 1.8.1.9 (thioredoxin reductase) inhibitor;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
flavouring agent;
food colouring;
geroprotector;
hepatoprotective agent;
immunomodulator;
iron chelator;
ligand;
lipoxygenase inhibitor;
metabolite;
neuroprotective agent;
nutraceutical;
radical scavenger
tamoxifenstilbenoid;
tertiary amino compound
angiogenesis inhibitor;
antineoplastic agent;
bone density conservation agent;
EC 1.2.3.1 (aldehyde oxidase) inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
estrogen antagonist;
estrogen receptor antagonist;
estrogen receptor modulator
cyclosporineramihyphin A: one of the metabolites produced by Fusarium sp. S-435; RN given refers to cpd with unknown MFhomodetic cyclic peptideanti-asthmatic drug;
anticoronaviral agent;
antifungal agent;
antirheumatic drug;
carcinogenic agent;
dermatologic drug;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
geroprotector;
immunosuppressive agent;
metabolite
biselyngbyasidebiselyngbyaside: antineoplastic from the marine cyanobacterium Lyngbya sp.; structure in first source
alpha-cyclopiazonic acidalpha-cyclopiazonic acids